1. Chen, Xianghong, Zhang, Zaozhang, Wang, Xingfan, Chen, Yuewu, Wang, Chao. 2020. NT5C2 Gene Polymorphisms and the Risk of Coronary Heart Disease. In Public health genomics, 23, 90-99. doi:10.1159/000507714. https://pubmed.ncbi.nlm.nih.gov/32541135/
2. Dieck, Chelsea L, Ferrando, Adolfo. 2019. Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL. In Blood, 133, 2263-2268. doi:10.1182/blood-2019-01-852392. https://pubmed.ncbi.nlm.nih.gov/30910786/
3. Duarte, Rodrigo R R, Bachtel, Nathaniel D, Côtel, Marie-Caroline, Powell, Timothy R, Srivastava, Deepak P. 2019. The Psychiatric Risk Gene NT5C2 Regulates Adenosine Monophosphate-Activated Protein Kinase Signaling and Protein Translation in Human Neural Progenitor Cells. In Biological psychiatry, 86, 120-130. doi:10.1016/j.biopsych.2019.03.977. https://pubmed.ncbi.nlm.nih.gov/31097295/
4. İpek, Rojan, Kömür, Mustafa, Direk, Meltem Çobanoğulları, Bozdoğan, Sevcan Tuğ, Okuyaz, Çetin. 2024. Two Sibling Cases of Spastic Paraplegia-45 with a Novel Pathogenic Variant in NT5C2 Gene: Concomitant RYR1 Gene in One Sibling. In Molecular syndromology, 15, 297-302. doi:10.1159/000536183. https://pubmed.ncbi.nlm.nih.gov/39119448/